Statin potency and the risk of hospitalization for community‐acquired pneumonia

摘要

AimPrevious studies suggest that statins may have beneficial respiratory effects. However, it is unclear if these purported benefits vary with statin potency. Our objective was to determine if higher potency statins, compared with lower potency statins, were associated with a reduced risk of hospitalization for community‐acquired pneumonia (HCAP).